An early decrease in release of aquaporin-2 in urinary extracellular vesicles after cisplatin treatment in rats

23Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Aquaporin-1 (AQP1) and AQP2 are important proteins involved in the regulation of renal water handling. Both AQPs have been found in urinary extracellular vesicles (uEVs) (uEV-AQP1 and -AQP2). Cisplatin, an antineoplastic agent, is known to down-regulate renal AQP1 and AQP2. However, the effect of cisplatin on the release of uEV-AQP1 and -AQP2 is largely unknown. In this study, we examined whether treatment of rats with cisplatin affected the release of uEV-AQP1 and -AQP2. Blood tests indicated that renal function was little altered at 24 h after cisplatin treatment but thereafter decreased dramatically at all of the other time points examined. Release of uEV-AQP1 was slightly increased at 24 h and decreased at 168 h. On the other hand, release of uEV-AQP2 was decreased dramatically at 24 h, and the decrease was maintained during the experimental period. These data suggest that uEV-AQP2 can be used to detect early renal impairment due to cisplatin. Furthermore, a combination of uEV-AQP2 and -AQP1 may be useful for estimation of cisplatininduced renal injury in a stage-dependent manner.

Cite

CITATION STYLE

APA

Sonoda, H., Oshikawa-Hori, S., & Ikeda, M. (2019). An early decrease in release of aquaporin-2 in urinary extracellular vesicles after cisplatin treatment in rats. Cells, 8(2). https://doi.org/10.3390/cells8020139

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free